Patent Expiry
INVA: ANORO ELLIPTA: recorded patent 11090294 expiry
November 29, 2030 · UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- November 29, 2030
- Company
- Innoviva, Inc. (INVA)
- Drug
- UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
ANORO ELLIPTA: recorded patent 11090294 expiry
Orange Book application NDA203975, product 001, listed patent 11090294 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Innoviva, Inc. (INVA)
- Drug
- UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE